Zhengzheng Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhengzheng Zhou has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
Liang Li
Department of Forensic Medicine, Zhongshan School of Medicine
7 shared publicationsJiaquan Li
Southern Medical University
6 shared publicationsChang Zhang
Southern Medical University
5 shared publicationsJianting Li
NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Hygiene Inspection & Quarantine Science, School of Public Health, Southern Medical University, Guangzhou, Guangdong 510515, China
5 shared publicationsYang Lu
5 shared publicationsChenyu Wu
4 shared publications
Latest Publications
- 6 November 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
Solvent-Reconfigured Polymorphic Transition of Lamotrigine-Salicylic Acid Salts
Solvent-reconfigured hydrogen bonding governs the polymorphic landscape of lamotrigine-salicylic acid salts. Two anhydrous polymorphs (forms I/II) and three solvates (ethanol, acetonitrile, ethyl acetate) were designed and prepared, with crystal analysis confirming their distinct structural motifs: isolated site packing in ethanol and acetonitrile solvates versus channel type topology in the ethyl acetate solvate, whose 25.8% void volume drives rapid desolvation and instability. Molecular electrostatic potential and Hirshfeld surface analyses revealed solvent-specific hydrogen bonds. Solvent-mediated transition studies showed that, under the investigated conditions, form I was the phase ultimately obtained. This study elucidates the solvent driven hydrogen bond reconfiguration in polymorphism, establishing a mechanistic framework for the rational design of multicomponent pharmaceutical salts.
- 6 November 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
Solvent-Reconfigured Polymorphic Transition of Lamotrigine-Salicylic Acid Salts
Solvent-reconfigured hydrogen bonding governs the polymorphic landscape of lamotrigine-salicylic acid salts. Two anhydrous polymorphs (forms I/II) and three solvates (ethanol, acetonitrile, ethyl acetate) were designed and prepared, with crystal analysis confirming their distinct structural motifs: isolated site packing in ethanol and acetonitrile solvates versus channel type topology in the ethyl acetate solvate, whose 25.8% void volume drives rapid desolvation and instability. Molecular electrostatic potential and Hirshfeld surface analyses revealed solvent-specific hydrogen bonds. Solvent-mediated transition studies showed that, under the investigated conditions, form I was the phase ultimately obtained. This study elucidates the solvent driven hydrogen bond reconfiguration in polymorphism, establishing a mechanistic framework for the rational design of multicomponent pharmaceutical salts.
- 26 March 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 17 (14) , 4080-4088
META-Tox: Multiview Ensemble with Topological Aggregation for Robust In Vivo Toxicity Prediction
Accurate prediction of in vivo toxicity end points is a pivotal challenge in drug discovery, primarily constrained by data scarcity and sharp activity cliffs. Existing knowledge transfer approaches often fail because they rely heavily on implicit semantic representations while neglecting the explicit geometric constraints required to distinguish structurally similar but toxically distinct compounds. To bridge this gap, we present META-Tox, a Multi-view Ensemble framework leveraging Topological Aggregation to explicitly augment LLM-derived semantics with comprehensive structural constraints (spanning 2D graphs and 3D conformations). Specifically, META-Tox employs a tiered meta-learning architecture with adaptive feature selection to rigorously filter redundant noise and fuse heterogeneous structural insights. Notably, our topological aggregation strategy amplifies the performance gains of standard LLM fine-tuning by nearly 3-fold (5.4% vs 1.9% gain over the baseline). Furthermore, qualitative analysis via case studies demonstrates the framework’s potential to navigate activity cliffs by capturing subtle structural nuances. Ultimately, extensive evaluations confirm that META-Tox establishes a new state-of-the-art benchmark on independent external data sets with an AUC of 0.772, offering a robust solution for minimizing safety attrition in early drug development.
- 26 March 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry Letters
- Vol. 17 (14) , 4080-4088
META-Tox: Multiview Ensemble with Topological Aggregation for Robust In Vivo Toxicity Prediction
Accurate prediction of in vivo toxicity end points is a pivotal challenge in drug discovery, primarily constrained by data scarcity and sharp activity cliffs. Existing knowledge transfer approaches often fail because they rely heavily on implicit semantic representations while neglecting the explicit geometric constraints required to distinguish structurally similar but toxically distinct compounds. To bridge this gap, we present META-Tox, a Multi-view Ensemble framework leveraging Topological Aggregation to explicitly augment LLM-derived semantics with comprehensive structural constraints (spanning 2D graphs and 3D conformations). Specifically, META-Tox employs a tiered meta-learning architecture with adaptive feature selection to rigorously filter redundant noise and fuse heterogeneous structural insights. Notably, our topological aggregation strategy amplifies the performance gains of standard LLM fine-tuning by nearly 3-fold (5.4% vs 1.9% gain over the baseline). Furthermore, qualitative analysis via case studies demonstrates the framework’s potential to navigate activity cliffs by capturing subtle structural nuances. Ultimately, extensive evaluations confirm that META-Tox establishes a new state-of-the-art benchmark on independent external data sets with an AUC of 0.772, offering a robust solution for minimizing safety attrition in early drug development.
- Open Access
Tecovirimat-Related Substance: Characterization, Hirshfeld Analysis, Theoretical Study, In Silico Toxicity Assessment
Crystal structures of 4-(trifluoromethyl)benzene-1-carbohydrazide (1), 4-(trifluoromethyl)-N’-{[4-(trifluoromethyl)phenyl]carbonyl}benzohydrazide (2) and (1R,2S,6R,7S,8S,10R)-4-({[4-(trifluoromethyl)phenyl]carbonyl}amino)-4-azatetracyclo [5.3.2.08,10.02,6]dodec-11-ene-3,5-dione (3) were first reported. Besides the three new single-crystal structures, the single-crystal structure of tecovirimat (4) was also described herein. Hirshfeld analysis quantified intermolecular interactions, and PXRD confirmed high crystal phase purity. DSC data and packing energy calculations demonstrated that the melting point order matched the magnitude of packing energies for compounds with similar structures and analogous intermolecular interactions. According to the ICH M7 guidelines, in silico genotoxicity assessment using Derek Nexus and Sarah Nexus indicated that 2 showed no structural alerts for genotoxicity (ICH M7 Class 5), whereas 1 and 3 were classified as ICH M7 Class 3 due to structural features associated with potential genotoxicity, warranting further experimental evaluation.
Open AccessTecovirimat-Related Substance: Characterization, Hirshfeld Analysis, Theoretical Study, In Silico Toxicity Assessment
Crystal structures of 4-(trifluoromethyl)benzene-1-carbohydrazide (1), 4-(trifluoromethyl)-N’-{[4-(trifluoromethyl)phenyl]carbonyl}benzohydrazide (2) and (1R,2S,6R,7S,8S,10R)-4-({[4-(trifluoromethyl)phenyl]carbonyl}amino)-4-azatetracyclo [5.3.2.08,10.02,6]dodec-11-ene-3,5-dione (3) were first reported. Besides the three new single-crystal structures, the single-crystal structure of tecovirimat (4) was also described herein. Hirshfeld analysis quantified intermolecular interactions, and PXRD confirmed high crystal phase purity. DSC data and packing energy calculations demonstrated that the melting point order matched the magnitude of packing energies for compounds with similar structures and analogous intermolecular interactions. According to the ICH M7 guidelines, in silico genotoxicity assessment using Derek Nexus and Sarah Nexus indicated that 2 showed no structural alerts for genotoxicity (ICH M7 Class 5), whereas 1 and 3 were classified as ICH M7 Class 3 due to structural features associated with potential genotoxicity, warranting further experimental evaluation.
- 24 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 152, 157883
Herbal-derived puerarin-berberine cocrystal: Computational insights into mechanisms driving simultaneous enhanced solubility and bioavailability
- 24 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 152, 157883
Herbal-derived puerarin-berberine cocrystal: Computational insights into mechanisms driving simultaneous enhanced solubility and bioavailability
- 20 January 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1358
Polymorphic Cocrystallization: Substantially enhancing aceclofenac solubility across diverse pH conditions
- 20 January 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1358
Polymorphic Cocrystallization: Substantially enhancing aceclofenac solubility across diverse pH conditions
- 11 September 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (11)
From traditional screening to machine learning facilitated development of pharmaceutical cocrystals
- 11 September 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (11)
From traditional screening to machine learning facilitated development of pharmaceutical cocrystals
- 15 July 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1347
Concurrent modulation of solubility and antibacterial activity in trimethoprim-meloxicam drug-drug salt
- 15 July 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1347
Concurrent modulation of solubility and antibacterial activity in trimethoprim-meloxicam drug-drug salt
- Open Access
- 21 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (14) , 5797-5802
How elastically flexible can molecular crystals be? – a new record
The elastic strain limit can reach up to 8.7% for form I celecoxib crystals grown via melt crystallization.
- 21 March 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (14) , 5797-5802
Open AccessHow elastically flexible can molecular crystals be? – a new record
The elastic strain limit can reach up to 8.7% for form I celecoxib crystals grown via melt crystallization.
- 4 February 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 36 (7)
Unpacking phase transitions in multi-component drug systems: A case study
- 4 February 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 36 (7)
Unpacking phase transitions in multi-component drug systems: A case study